Trial Profile
A phase II trial of Ren-009 for the treatment of critical limb ischaemia
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 30 Mar 2016
Price :
$35
*
At a glance
- Drugs ReN 009 (Primary)
- Indications Peripheral ischaemia
- Focus Therapeutic Use
- 30 Mar 2016 New trial record